OPTIMAL LIDOCAINE DOSING IN PATIENTS WITH MYOCARDIAL-INFARCTION

被引:6
作者
LOPEZ, LM [1 ]
MEHTA, JL [1 ]
ROBINSON, JD [1 ]
ROBERTS, RJ [1 ]
机构
[1] UNIV FLORIDA,COLL MED,GAINESVILLE,FL 32610
关键词
D O I
10.1097/00007691-198208000-00004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:271 / 276
页数:6
相关论文
共 16 条
[11]   CLINICAL USE AND TOXICITY OF INTRAVENOUS LIDOCAINE - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM [J].
PFEIFER, HJ ;
GREENBLATT, DJ ;
KOCHWESER, J .
AMERICAN HEART JOURNAL, 1976, 92 (02) :168-173
[12]  
PRESCOTT LF, 1971, LIDOCAINE TREATMENT, P168
[13]  
RIBNER HS, 1979, PROG CARDIOVASC DIS, V21, P499
[14]  
RODMAN JH, 1980, APPLIED PHARMACOKINE, P350
[15]   LIDOCAINE PHARMACOKINETICS IN ADVANCED HEART-FAILURE, LIVER-DISEASE, AND RENAL-FAILURE IN HUMANS [J].
THOMSON, PD ;
MELMON, KL ;
RICHARDSON, JA ;
COHN, K ;
STEINBRUNN, W ;
CUDIHEE, R ;
ROWLAND, M .
ANNALS OF INTERNAL MEDICINE, 1973, 78 (04) :499-508
[16]   LIDOCAINE KINETICS PREDICTED BY INDOCYANINE GREEN CLEARANCE [J].
ZITO, RA ;
REID, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (21) :1160-1163